Consensus Meeting29 November 2013 hosted by FIFA at the Home of FIFAin Zurich, Switzerland
Time for Change
The principal areas include:
Anabolic agents in sport
Biological profile of individual athletes
Autologous blood transfusion
Erythopaesis stimulating agents
Ethical and legal considerations
WADA and CAS perspective
Following the conference, a group of experts will form a panel to draft consensus statement and the successful publication. The expected journal publication of the outcome statement will be June 2014.
We are pleased to announce the Call for Abstracts for the Anti-Doping in Sports Consensus Meeting which will be held on 29 November 2013 in Zurich, Switzerland.
You are invited to submit an abstract of original research related to anti-doping for consideration as a presentation at this meeting. The main topic areas have been determined by the scientific committee and reflect key consensus questions to be discussed. The principal consensus includes:
• Anabolic agents in sport
• Biological profile of individual athletes
• Autologous blood transfusion
• Erythopaesis stimulating agents
• Ethical and legal considerations
GUIDELINES FOR ABSTRACT SUBMISSION
Page 1 of the abstract submission must include the following information in the following order:
• Complete title
• author’s full names, highest academic degrees and affiliations
• name and address for correspondence, including fax number, telephone number and e-mail address
• acknowledgments and conflicts of interest
• The category that best describes the abstract: (as listed above or miscellaneous if the abstract does not fit in any of the preceding categories).
Page 2 of the abstract submission should contain only the abstract in the following format:
• Please type single spaced using 12 point font size in English
• Submitted manuscripts should have at least a 1-inch (2,5-cm) margin on all sides.
• Maximum abstract length of 250 words (not including author’s and institution names).
• A “structured abstract” format should be used with the headings as seen in the attached sample abstract. A more detailed description of the structured abstract format can be found at the Clinical Journal of Sport Medicine website (http://www.cjsportmed.com) under the “For Authors” link.
• The abstract title should be CAPITALIZED in bold, followed the author’s names in underline. The authors’ names, in underline should appear next, followed by the institution name. The presenting author’s name should be indicated with an asterix (*). There should be a line space separating the text from the institution. Each section heading should be in bold, with each section beginning on a new line. A line space is not required between each section. Abstracts will appear in print exactly as typed.
• Abstracts presented elsewhere will be accepted. However, this work must not be published as a full paper in a journal by the time of the meeting or have appeared in print elsewhere (except in abstract form) prior to the meeting.
• All authors must sign the disclosure statement listed below. It is not the intention of the disclosure to prevent authors who have a known conflict of interest from presenting their work, rather it is to provide conference participants with adequate information to make their own judgments as to the scientific and financial independence of a speaker.
ABSTRACTS THAT DO NOT FOLLOW THE ABOVE FORMAT WILL AUTOMATICALLY BE REJECTED WITHOUT REVIEW.
Abstract submission deadline:
Abstracts should be submitted by e-mail as an attached MS Word or rtf document to email@example.com by Sunday, 13 October 2013.
The disclosure statement can be scanned and emailed (preference), or faxed to: +41 43 222 75 03, also by Sunday, 13 October 2013. The abstract will be rejected if the disclosure form, signed by all authors, is not sent.